318 related articles for article (PubMed ID: 23651395)
1. Delivery of poorly soluble compounds by amorphous solid dispersions.
Lee TW; Boersen NA; Hui HW; Chow SF; Wan KY; Chow AH
Curr Pharm Des; 2014; 20(3):303-24. PubMed ID: 23651395
[TBL] [Abstract][Full Text] [Related]
2. Application of spray-drying and electrospraying/electospinning for poorly water-soluble drugs: a particle engineering approach.
Bohr A; Boetker JP; Rades T; Rantanen J; Yang M
Curr Pharm Des; 2014; 20(3):325-48. PubMed ID: 23651398
[TBL] [Abstract][Full Text] [Related]
3. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
Meng F; Gala U; Chauhan H
Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
[TBL] [Abstract][Full Text] [Related]
4. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
Bikiaris DN
Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
[TBL] [Abstract][Full Text] [Related]
5. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
Baghel S; Cathcart H; O'Reilly NJ
J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
[TBL] [Abstract][Full Text] [Related]
6. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
[TBL] [Abstract][Full Text] [Related]
7. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
Vo CL; Park C; Lee BJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):799-813. PubMed ID: 24056053
[TBL] [Abstract][Full Text] [Related]
8. Solid dispersions: a review.
Dhirendra K; Lewis S; Udupa N; Atin K
Pak J Pharm Sci; 2009 Apr; 22(2):234-46. PubMed ID: 19339238
[TBL] [Abstract][Full Text] [Related]
9. Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents.
Alshehri S; Imam SS; Hussain A; Altamimi MA; Alruwaili NK; Alotaibi F; Alanazi A; Shakeel F
Drug Deliv; 2020 Nov; 27(1):1625-1643. PubMed ID: 33207947
[TBL] [Abstract][Full Text] [Related]
10. The Application of Modeling and Prediction to the Formation and Stability of Amorphous Solid Dispersions.
DeBoyace K; Wildfong PLD
J Pharm Sci; 2018 Jan; 107(1):57-74. PubMed ID: 28389266
[TBL] [Abstract][Full Text] [Related]
11. Recent advances and patents in solid dispersion technology.
Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK
Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778
[TBL] [Abstract][Full Text] [Related]
12. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.
Srinarong P; de Waard H; Frijlink HW; Hinrichs WL
Expert Opin Drug Deliv; 2011 Sep; 8(9):1121-40. PubMed ID: 21722000
[TBL] [Abstract][Full Text] [Related]
13. Multiple Linear Regression Modeling To Predict the Stability of Polymer-Drug Solid Dispersions: Comparison of the Effects of Polymers and Manufacturing Methods on Solid Dispersion Stability.
Fridgeirsdottir GA; Harris RJ; Dryden IL; Fischer PM; Roberts CJ
Mol Pharm; 2018 May; 15(5):1826-1841. PubMed ID: 29533634
[TBL] [Abstract][Full Text] [Related]
14. Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review.
Ellenberger DJ; Miller DA; Williams RO
AAPS PharmSciTech; 2018 Jul; 19(5):1933-1956. PubMed ID: 29846889
[TBL] [Abstract][Full Text] [Related]
15. Solubilization of poorly water-soluble drugs using solid dispersions.
Tran TT; Tran PH; Khanh TN; Van TV; Lee BJ
Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):122-33. PubMed ID: 23244679
[TBL] [Abstract][Full Text] [Related]
16. Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products.
Pandi P; Bulusu R; Kommineni N; Khan W; Singh M
Int J Pharm; 2020 Aug; 586():119560. PubMed ID: 32565285
[TBL] [Abstract][Full Text] [Related]
17. Review: physical chemistry of solid dispersions.
Janssens S; Van den Mooter G
J Pharm Pharmacol; 2009 Dec; 61(12):1571-86. PubMed ID: 19958579
[TBL] [Abstract][Full Text] [Related]
18. Amorphous solid dispersions: a robust platform to address bioavailability challenges.
Newman A; Nagapudi K; Wenslow R
Ther Deliv; 2015 Feb; 6(2):247-61. PubMed ID: 25690090
[TBL] [Abstract][Full Text] [Related]
19. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
Dhumal RS; Biradar SV; Aher S; Paradkar AR
J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
[TBL] [Abstract][Full Text] [Related]
20. Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updates.
Alam MA; Ali R; Al-Jenoobi FI; Al-Mohizea AM
Expert Opin Drug Deliv; 2012 Nov; 9(11):1419-40. PubMed ID: 23043303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
